Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
Prognostic value of number of negative lymph node in patients with stage II and IIIa non-small cell lung cancer. [electronic resource] by
- Wang, Shengguang
- Zhang, Bin
- Li, Chenguang
- Cui, Chao
- Yue, Dongsheng
- Shi, Bowen
- Zhang, Qiang
- Zhang, Zhenfa
- Zhang, Xi
- Wang, Changli
Publication details: Oncotarget Oct 2017
In:
Oncotarget vol. 8
Availability: No items available.
|
|
7.
|
MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS. [electronic resource] by
- Fan, Qian
- Hu, Xiuting
- Zhang, Haiyang
- Wang, Shengguang
- Zhang, Huilai
- You, Chaoying
- Zhang, Chen-Yu
- Liang, Hongwei
- Chen, Xi
- Ba, Yi
Producer: 20180118
In:
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology vol. 44
Availability: No items available.
|
|
8.
|
Prognostic value analysis of mutational and clinicopathological factors in non-small cell lung cancer. [electronic resource] by
- Li, Chenguang
- Hao, Ligang
- Li, Yue
- Wang, Shengguang
- Chen, Hui
- Zhang, Lianmin
- Ke, Bin
- Yin, Yuesong
- Suo, Haijin
- Sun, Bingsheng
- Zhang, Bin
- Wang, Changli
Producer: 20151216
In:
PloS one vol. 9
Availability: No items available.
|
|
9.
|
Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC. [electronic resource] by
- Liu, Weiran
- Yin, Yuesong
- Wang, Jun
- Shi, Bowen
- Zhang, Lianmin
- Qian, Dong
- Li, Chenguang
- Zhang, Hua
- Wang, Shengguang
- Zhu, Jinfang
- Gao, Liuwei
- Zhang, Qiang
- Jia, Bin
- Hao, Ligang
- Wang, Changli
- Zhang, Bin
Producer: 20180305
In:
Oncotarget vol. 8
Availability: No items available.
|